Stock DNA
Pharmaceuticals & Biotechnology
CAD 249 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.43
-28.41%
1.79
Revenue and Profits:
Net Sales:
41 Million
(Quarterly Results - Jun 2025)
Net Profit:
-4 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-27.13%
0%
-27.13%
6 Months
-30.88%
0%
-30.88%
1 Year
-45.35%
0%
-45.35%
2 Years
-4.08%
0%
-4.08%
3 Years
74.07%
0%
74.07%
4 Years
-44.05%
0%
-44.05%
5 Years
0%
0%
0.0%
HealWELL AI, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

HealWELL AI, Inc. Hits Day High with Strong 7.8% Intraday Surge
HealWELL AI, Inc. has seen a significant rise in its stock price on October 14, 2025, contrasting with a decline in the S&P/TSX 60. The company has experienced a 15.15% gain over the past month, despite a year-to-date decline and ongoing profitability challenges reflected in its financial metrics.
Read More Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
15.20%
EBIT Growth (5y)
-266.27%
EBIT to Interest (avg)
-13.36
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
2.88
Tax Ratio
4.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.79
EV to EBIT
-7.80
EV to EBITDA
-11.60
EV to Capital Employed
1.55
EV to Sales
3.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-19.92%
ROE (Latest)
-28.41%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
40.50
14.10
187.23%
Operating Profit (PBDIT) excl Other Income
-1.70
-9.40
81.91%
Interest
1.90
1.30
46.15%
Exceptional Items
3.10
-1.40
321.43%
Consolidate Net Profit
-4.10
-14.10
70.92%
Operating Profit Margin (Excl OI)
-204.90%
-822.60%
61.77%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 187.23% vs -7.24% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 70.92% vs -19.49% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
39.00
7.30
434.25%
Operating Profit (PBDIT) excl Other Income
-23.60
-11.20
-110.71%
Interest
2.60
2.00
30.00%
Exceptional Items
4.80
-16.40
129.27%
Consolidate Net Profit
-27.40
-32.10
14.64%
Operating Profit Margin (Excl OI)
-792.00%
-1,988.00%
119.60%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 434.25% vs -86.28% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 14.64% vs -52.86% in Dec 2023
About HealWELL AI, Inc. 
HealWELL AI, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






